Santen Pharmaceutical Co (TSE:4536) Accounts Payable & Accrued Expense : 円48,658 Mil (As of Mar. 2024)

View and export this data going back to 1964. Start your Free Trial

What is Santen Pharmaceutical Co Accounts Payable & Accrued Expense?

Santen Pharmaceutical Co's quarterly accounts payable & accrued expense declined from Sep. 2023 (円49,227 Mil) to Dec. 2023 (円47,547 Mil) but then increased from Dec. 2023 (円47,547 Mil) to Mar. 2024 (円48,658 Mil).

Santen Pharmaceutical Co's annual accounts payable & accrued expense increased from Mar. 2022 (円45,383 Mil) to Mar. 2023 (円51,690 Mil) but then declined from Mar. 2023 (円51,690 Mil) to Mar. 2024 (円48,658 Mil).

Santen Pharmaceutical Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Santen Pharmaceutical Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Santen Pharmaceutical Co Accounts Payable & Accrued Expense Chart

Santen Pharmaceutical Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

39,426.00

43,564.00

45,383.00

51,690.00

48,658.00

Santen Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															51,690.00	44,462.00	49,227.00	47,547.00	48,658.00

Santen Pharmaceutical Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Santen Pharmaceutical Co (TSE:4536) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Santen Pharmaceutical Co Ltd (TSE:4536) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

SNPHY:USA SNPHF:USA SZD:Germany

Address

Grand Front Osaka Tower A, 4-20 Ofuka-cho, Kita-ku, Osaka, JPN, 530-8552

Website

http://www.santen.co.jp

Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. The company reports two primary operating segments: prescription ophthalmic pharmaceuticals and other. The pharmaceuticals segment includes over-the-counter pharmaceuticals, while the other segment includes medical devices. The vast majority of Santen's revenue is derived from its prescription ophthalmic pharmaceuticals segment, which manufactures and distributes prescription and OTC pharmaceuticals. Most of Santen's sales are generated in Japan, followed by other Asian countries.

Santen Pharmaceutical Co (TSE:4536) Headlines

No Headlines